Protek OAO (P) operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Protek OAO (P) with three other
pharmaceutical manufacturers in Europe:
Lonza Group AG
sales of 3.80 billion Swiss Francs [US$3.84 billion]
of which 57%
was Specialty Ingredients),
(19.65 billion Swedish Kronor [US$2.23 billion]
of which 62%
was RX), and
Stada Arzneimittel AG
based in Germany
(2.12 billion Euro [US$2.32 billion]
of which 58%
During the year ended December of 2015, sales at
Protek OAO (P) were 195.31 billion Russian Rubles (US$3.12 billion).
increase of 24.4%
versus 2014, when the company's sales were 156.95 billion Russian Rubles.
This was the fifth consecutive year of sales increases at Protek OAO (P)
(and since 2010, sales have increased a total of 96%).
Sales of Distribution saw an increase
24.7% in 2015, from
127.46 billion Russian Rubles to 158.94 billion Russian Rubles.